These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 24831826)

  • 1. Small molecule inhibitors targeting activator protein 1 (AP-1).
    Ye N; Ding Y; Wild C; Shen Q; Zhou J
    J Med Chem; 2014 Aug; 57(16):6930-48. PubMed ID: 24831826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention.
    Tewari D; Nabavi SF; Nabavi SM; Sureda A; Farooqi AA; Atanasov AG; Vacca RA; Sethi G; Bishayee A
    Pharmacol Res; 2018 Feb; 128():366-375. PubMed ID: 28951297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Small Molecules Inhibiting Activator Protein-1 DNA Binding Probed with Induced Fit Docking and Metadynamics Simulations.
    Yin Z
    J Chem Inf Model; 2019 Dec; 59(12):5276-5280. PubMed ID: 31774677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.
    Gelain A; Mori M; Meneghetti F; Villa S
    Curr Med Chem; 2019; 26(27):5165-5206. PubMed ID: 30027840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
    Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
    J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain.
    Makino H; Seki S; Yahara Y; Shiozawa S; Aikawa Y; Motomura H; Nogami M; Watanabe K; Sainoh T; Ito H; Tsumaki N; Kawaguchi Y; Yamazaki M; Kimura T
    Sci Rep; 2017 Dec; 7(1):16983. PubMed ID: 29208967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products triggering biological targets--a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis.
    Chen S
    Curr Drug Targets; 2011 Mar; 12(3):288-301. PubMed ID: 20955151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3: A Potential Drug Target for Tumor and Inflammation.
    Hu YS; Han X; Liu XH
    Curr Top Med Chem; 2019; 19(15):1305-1317. PubMed ID: 31218960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
    Chaudhary D; Robinson S; Romero DL
    J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
    Zaka M; Abbasi BH; Durdagi S
    J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.
    Zenz R; Eferl R; Scheinecker C; Redlich K; Smolen J; Schonthaler HB; Kenner L; Tschachler E; Wagner EF
    Arthritis Res Ther; 2008; 10(1):201. PubMed ID: 18226189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments of small molecule EGFR inhibitors based on the quinazoline core scaffolds.
    Yu-Jing YJ; Zhang CM; Liu ZP
    Anticancer Agents Med Chem; 2012 May; 12(4):391-406. PubMed ID: 22043991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90 is required for increased DNA binding activity of activator protein-1, a heterodimer of Fos/JunD, in rheumatoid synovial cells under inflammatory stimuli.
    Murata M; Miura Y; Hashiramoto A; Kitamura H; Kawasaki H; Shiozawa K; Yoshiya S; Baba H; Chihara K; Shiozawa S
    Int J Mol Med; 2005 Apr; 15(4):649-53. PubMed ID: 15754027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.
    Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T
    Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
    Furtek SL; Backos DS; Matheson CJ; Reigan P
    ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Hedgehog Signaling Pathway with Small Molecules from Natural Sources.
    Petricci E; Manetti F
    Curr Med Chem; 2015; 22(35):4058-90. PubMed ID: 26337106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory activity of Khayandirobilide A from Khaya senegalensis via NF-κB, AP-1 and p38 MAPK/Nrf2/HO-1 signaling pathways in lipopolysaccharide-stimulated RAW 264.7 and BV-2 cells.
    Zhou MM; Zhang WY; Li RJ; Guo C; Wei SS; Tian XM; Luo J; Kong LY
    Phytomedicine; 2018 Mar; 42():152-163. PubMed ID: 29655681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?
    Malemud CJ
    Future Med Chem; 2015; 7(9):1137-47. PubMed ID: 26132523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.